Contract manufacturing trends: part one
Changes to the pharmaceutical industry over the last ten years, such as rising price pressures and increasingly complex drugs, have…
CEO spotlight: Sterling Pharma Solutions
A conversation with Kevin Cook about CDMO-sponsor partnerships and outsourcing
Kevin Cook, CEO at Sterling Pharma Solutions recently spoke with Contract Pharma about building and maintaining successful partnerships with sponsors in the outsourcing space.
From how outsourcing relationships have evolved over the last decade with a shift from tactically outsourcing on a project basis to developing long-term strategic partnerships to the future of outsourcing and the prominence of consolidation going forward, the article examines the changing outsourcing landscape for drug manufacturers.
You can read the full article here: http://bit.ly/2EQ48f1
Related
Continuous vs. batch production
While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…
Biocatalysis whitepaper
Click to download our Biocatalysis whitepaper: 'Leveraging nature's catalysts in pharmaceutical development'. Click here to learn more about our biocatalysis…
Controlled and effective hazardous chemistry
There is a growing demand for hazardous chemistry techniques for synthetic manufacturing processes, propelled by the increasing complexity of new…